Search tips
Search criteria 


Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
Nat Cell Biol. Author manuscript; available in PMC 2011 May 9.
Published in final edited form as:
PMCID: PMC3090258

A novel function of Drosophila eIF4A as a negative regulator of Dpp/BMP signalling that mediates SMAD degradation


Signalling by the TGF-β superfamily member and BMP orthologue Decapentaplegic (Dpp) is crucial for multiple developmental programmes and has to be tightly regulated. Here, we demonstrate that the Drosophila Dpp pathway is negatively regulated by eukaryotic translation initiation factor 4A (eIF4A), which mediates activation-dependent degradation of the Dpp signalling components Mad and Medea. eIF4A mutants exhibit increased Dpp signalling and accumulation of Mad and phospho-Mad. Overexpression of eIF4A decreases Dpp signalling and causes loss of Mad and phospho-Mad. Furthermore, eIF4A physically associates with Mad and Medea, and promotes their degradation following activation of Dpp signalling in a translation-independent manner. Finally, we show that eIF4A acts synergistically with, but independently of, the ubiquitin ligase DSmurf, indicating that a dual system controls SMAD degradation. Thus, in addition to being an obligatory component of the cap-dependent translation initiation complex, eIF4A has a novel function as a specific inhibitor of Dpp signalling that mediates the degradation of SMAD homologues.

To understand the regulation of Dpp signalling, we have previously identified a dominant-negative mutation in eukaryotic translation initiation factor 4A (eIF4A), which acts as a suppressor of dpp haploinsufficiency1. This allele, eIF4AR321H (also known as eIF4AYE9), is associated with an increased number of amnioserosa cells1, the fate of which is determined by Dpp in the early Drosophila embryo2. To investigate whether eIF4A mutations cause increased Dpp signalling in general, we examined the effects of eIF4A mutations on Dpp signalling in other developmental or genetic contexts. First, we found that eIF4AR321H and eIF4A1006 (a null allele1,3) dominantly suppressed the sterility of females that were doubly heterozygous for null mutations of Mad and saxophone (sax) (see Methods), which encode homologues of mammalian Smad1/5/8 and type I activin receptor, respectively48. Embryos that are produced by Mad sax1/+ female flies die with a partially ventralized phenotype (data not shown; also see refs 5, 6). In contrast, Mad sax1/eIF4AR321H and Mad sax1/eIF4A1006 females laid morphologically normal eggs that hatched to viable adult progeny (Table 1), indicating that reducing the amount of eIF4A can compensate for a reduced maternal Mad and sax dosage for embryonic viability. Second, eIF4AR321H and eIF4A1006 dominantly suppressed the partial lethality and ‘thick vein’ phenotype that was associated with reduced levels of the type I receptor Thickveins6,9 (Fig. 1a; Table 1), indicating that the effect of eIF4A mutations on Dpp signalling is not limited to embryogenesis. Third, transient ectopic expression of dpp induced by mild heat shock was tolerated in wild-type flies, but resulted in lethality in a eIF4AR321H/+ background, indicating that eIF4AR321H dominantly enhances the effects of dpp ectopic expression (Table 1). eIF4AR321H heterozygosity similarly enhanced the effects of overepxressing dpp by the eye-specific GMR–Gal4 (see below and Fig. 1h). Therefore, eIF4A mutations seem to augment the Dpp signalling strength.

Figure 1
Levels of eIF4A affect Dpp signalling and Mad protein levels. (a) Adult wings of different genotypes are shown anterior side up. Note the ‘thick veins’ (arrows) in the tkv1/tkv4 wing and the suppression by eIF4A1006 or eIF4AR321H. (b–e) ...
Table 1
Mutations in eIF4A augment Dpp signalling

To investigate at which step loss of eIF4A increases Dpp signalling, we examined the levels of active or phosphorylated Mad (pMad). In early wild-type embryos, pMad signals are detected in spatial and temporal patterns that are correlated with dpp expression10. At stage 10, pMad signals had dissipated from the procephalon and posterior midgut of wild-type embryos (Fig. 1b; also see refs 10, 11), but were still detected in eIF4AR321H embryos (Fig. 1b) — a phenotype that is very similar to that caused by loss of DSmurf11 — indicating a prolonged duration of Dpp signalling. Pronounced elevation and expansion of pMad signals were also detected in stage 11 (see Supplementary Information, Fig. S1) and stage 13 eIF4AR321H embryos (Fig. 1c). Consistent with the higher levels and expanded domains of pMad signals, we found that dpp expression in gc and ps7, which is subject to positive autoregulation, was also expanded in eIF4AR321H embryos (Fig. 1d). As we detected expanded domains but little or no ectopic pMad, and the initial pattern of dpp or pMad at stages 5–6 was not obviously changed in eIF4AR321H embryos (data not shown; see Supplementary Information, Fig. S1), the presence of higher levels and expanded domains of pMad signals in later embryonic stages indicate a prolonged Mad activation in eIF4AR321H embryos.

To understand the cause of the prolonged Mad activation, we examined Mad protein levels in eIF4AR321H embryos. Mad protein levels are generally low in all tissues, including ps7, in wild-type embryos (Fig. 1e; left). However, in eIF4AR321H embryos, elevated levels of Mad protein were found in ps7 (Fig. 1e; right). The observed accumulation of Mad protein is consistent with the idea that Mad protein levels are normally negatively controlled by protein degradation, and eIF4A mutations disrupt this process. Interestingly, the higher levels of Mad protein that were detected in eIF4AR321H embryos seemed to be nuclear localized, indicating that eIF4AR321H may interfere with the degradation of activated Mad.

To investigate whether eIF4A mutant cells autonomously increase Mad phosphorylation and protein levels, we generated cell clones that were mutant for a weak allele of eIF4A, eIF4A1069, as cells that are mutant for strong eIF4A alleles are not viable3. We examined multiple larval tissues and found increased pMad and Mad levels associated with eIF4A1069 mutant clones, most prominently in the presumptive adult gut (Fig. 1f, g). These results indicate that eIF4A mutations cause prolonged Mad phosphorylation, which might be due to reduced Mad degradation.

To test whether wild-type eIF4A antagonizes Dpp signalling, we expressed eIF4A using the Gal4/UAS system12. First, expressing one copy of UAS–eIF4A by the eye-specific GMR–Gal4, which by itself had little effects, completely neutralized the effects of ectopic dpp expression on eye development (Fig. 1h), indicating that overexpression of eIF4A antagonizes Dpp signalling. Conversely, expressing dpp by GMR–Gal4 in eIF4AR321H heterozygotes caused lethality, and the escapers had enlarged and deformed eyes (Fig. 1h), which is consistent with the idea that endogenous eIF4A antagonizes Dpp signalling. Second, expressing eIF4A by the wing-margin-specific C96–Gal4 resulted in ‘notches’ in the wing margin (Fig. 1i; right) — a phenotype that is similar to those produced by expressing dominant-negative molecules of the Dpp pathway, such as Put and Sax (Fig. 1i; middle). We examined pMad levels in 3rd instar imaginal discs and found a prominent loss of pMad signals in wing-margin primordial cells in which C96–Gal4 is expressed (Fig. 1j). These results are consistent with the notion that wild-type eIF4A negatively modulates Dpp signalling at the level of Mad protein regulation.

To investigate the molecular mechanism by which eIF4A negatively modulates Dpp signalling, we co-expressed Mad, Medea and eIF4AWT (or eIF4AR321H) in 293T cells with or without the activated form of Dpp receptor TkvQD, which is able to phosphorylate and activate Mad in a ligand-independent manner13. Medea is a co-Smad that is homologous to Smad4 (refs 14, 15). It has been reported that transfected Mad and Medea are localized in the cytoplasm, and cotransfection with TkvQD results in their nuclear translocation15. We found that, in the absence of TkvQD, eIF4AWT (or eIF4AR321H) and Mad were localized in the cytoplasm in the same nonuniform patterns (Fig. 2a, rows 1, 3). However, following co-transfection with TkvQD, in cells transfected with eIF4AWT, the levels of Mad were reduced and its nuclear translocation was not detectable (Fig. 2a, row 2). This is in contrast to cells without transfected eIF4A (see Supplementary Information, Fig. S2; also see ref. 15) or to those transfected with eIF4AR321H (Fig. 2a, row 4), which exhibit prominent Mad nuclear translocation. These results are consistent with the notion that eIF4AWT antagonizes and eIF4AR321H enhances Dpp signalling.

Figure 2
Physical association of eIF4A with Mad and Medea. (a) Flag–Mad, Myc–Medea, and eIF4AWT or eIF4AR321H were co-transfected into 293T cells with or without TkvQD. Cells were stained with anti-Flag (green), anti-eIF4A (magenta) and propidium ...

As transfected eIF4A and Mad both reside in the cytoplasm in similar patterns prior to Mad activation, we tested whether they physically interact with the following assays. First, in co-transfected 293T cells, we found that eIF4A was able to co-immunoprecipitate with either Mad or Medea (Fig. 2b), indicating that eIF4A physically interacts with both Mad and Medea in transfected cells. Second, we performed immunoprecipitation studies using embryo extracts, and found that eIF4AWT and, to a lesser extent, eIF4AR321H were co-immunoprecipitated with Mad from embryo extracts (Fig. 2c). Finally, we confirmed the physical interaction between Mad and eIF4A using bacterially expressed eIF4A protein fragments and embryo lysate. The results indicated that Mad binds to the full-length eIF4A (Fig. 2d, lane 6) mainly through the carboxyl terminus (Fig. 2d, lane 4), and has a lower affinity for the amino terminus or eIF4AR321H (Fig. 2d, lanes 5, 7). These results indicate that eIF4AWT is able to physically associate with Mad and that eIF4AR321H is less able to do so.

We next examined the protein levels of Mad and Medea in the presence or absence of eIF4A and/or Dpp signalling in transfected cells. We found that low levels of Dpp signalling (low concentration of TkvQD) induced a dramatic degradation of Mad and Medea, as well as eIF4A itself, in the presence of eIF4AWT (Fig. 3a, lane 6) but not eIF4AR321H (Fig. 3a, lane 7), or in the absence of TkvQD (Fig. 3a, lane 3). We further confirmed that eIF4A-induced Mad and Medea degradation depends on the dosage of TkvQD and the proteosome system. Degradation of Mad and Medea was detected in the absence of exogenous eIF4A at high doses but not low doses of TkvQD (Fig. 3b, lanes 2, 3). However, the presence of exogenous eIF4AWT or, to a lesser extent, eIF4AR321H resulted in the disappearance of Mad and Medea even at low doses of TkvQD (Fig. 3b, lanes 4, 6), and this effect was inhibited by the proteosome inhibitor MG-132 (Fig. 3b, lane 8), indicating that eIF4A promotes proteosome-dependent degradation of both Mad and Medea.

Figure 3
eIF4A promotes Dpp signalling-dependent Mad and Medea degradation. (a–b) eIF4A induces TkvQD-dependent degradation of Mad and Medea. (a) 293T cells were transfected with Flag–Mad, Myc–Medea and eIF4AWT (or eIF4AR321H) with or without ...

It has been shown that Mad is ubiquitinated prior to its degradation16. We found that eIF4A increased Dpp signal-dependent (+TkvQD) ubiquitination of Mad (Fig. 3c). Moreover, we found that eIF4A itself also appeared to be ubiquitinated and degraded following activation of Dpp signalling, as TkvQD caused a dramatic increase in eIF4A ubiquitination and degradation only in the presence of Mad and Medea, but not in their absence (Fig. 3d; compare lanes 2 and 4).

As the known function of eIF4A has been in translation initiation, it is formally possible that eIF4A might preferentially promote the translation of an inhibitor of the Dpp pathway. However, this is unlikely to be the case based on the following observations. First, when overexpressed in cultured cells, eIF4AR321H also promoted Mad and Medea degradation especially at high doses of Dpp signalling, albeit less efficiently than eIF4AWT (see Fig. 3b). This is presumably due to its ability to bind to Mad and Medea (see Fig. 2b–d) and to be ubiquitinated (see Fig. 3d). However, eIF4AR321H behaves genetically as a dominant-negative molecule in causing lethality and growth delay1, possibly by inhibiting general translation. Indeed, purified eIF4AR321H protein potently inhibited protein translation in an in vitro system in a dose-dependent manner (see Supplementary Information, Fig. S3a). These results indicate that the ability of eIF4A to inhibit Dpp signalling is separable from its function as a translation initiation factor. Second, inhibiting the eIF4F complex does not lead to increased Dpp signalling. Mutations in eIF4E cause lethality and larval growth delay17, phenotypes that are essentially identical to those of eIF4A. eIF4E is an essential regulatory subunit of the eIF4F complex17. However, none of the eIF4E mutants we tested caused increased Dpp signalling in a sensitized assay (see below and Fig. 4a; data not shown). We further examined the number of amnioserosa cells, which reflects the levels of Dpp signalling in the early embryo1,2. Unlike eIF4A or other Su(dpp) mutations1, eIF4E mutant embryos had a normal number of amnioserosa cells (see Supplementary Information, Fig. S3c). These results indicate that the negative modulation of Dpp signalling by eIF4A is independent of its function in protein translation.

Figure 4
eIF4A acts synergistally with and independently of DSmurf. (a) eIF4A mutations, but not those of eIF4E or activated TKV, interact synergistically with DSmurf mutations. The effects of maternal mutations on the viability of 1xdpp+ versus 3xdpp+ progeny ...

The ubiquitin E3 ligase DSmurf (encoded by lack) has been shown to negatively regulate Dpp signalling11 by specifically binding to and promoting degradation of phospho-Mad16. To investigate whether the function of eIF4A in mediating Mad degradation depends on DSmurf, we tested genetic interactions and the epistatic relationship between eIF4A and DSmurf mutations in a sensitized genetic assay. Flies with one copy and three copies of dpp+ (1xdpp+ and 3xdpp+, respectively) are inversely sensitive to maternal-effect mutations that increase Dpp signalling strength1,5,6. Increasing Dpp signalling promotes the viability of 1xdpp+ animals, which are normally not viable in an otherwise wild-type genetic background1,5,6, and decreases that of 3xdpp+ animals. Thus, when fathered by 0xdpp+/2xdpp+ males (see Methods), the ratio of F1 siblings inheriting 1xdpp+ versus 3xdpp+ is a sensitive measurement of the effects of genetic mutations carried by the mother on Dpp signalling.

This sensitized assay allowed us to make the following two findings with regards to eIF4A. First, we found that eIF4A and DSmurf mutations interact synergistically in trans-heterozygotes. Heterozygous mutations in eIF4A and DSmurf individually either did not rescue or moderately rescued the lethality of 1xdpp+ animals, such that when females that were heterozygous for eIF4A1006, eIF4AR321H or lackKG07014 (a strong allele) were mated to 0xdpp+/2xdpp+ males, the ratios of 1xdpp+ versus 3xdpp+ progeny in the F1 were 0 (no rescue), 0.15 and 0.29, respectively (Fig. 4a). However, transheterozygosity of eIF4A and DSmurf mutations produced synergistic effects on the viability of F1 progeny, dramatically increasing the number of 1xdpp+ offspring at the expense of their 3xdpp+ siblings, resulting in ratios of 1.2 and 1.4, respectively (Fig. 4a). Generally increasing Dpp signalling did not result in synergistic interaction with DSmurf. Specifically, low-level expression of the activative TkvQD molecule (using hs–Gal4/UAS–TkvQD females under mild heat-shock conditions) can suppress dpp haplo-lethality, resulting in a 1xdpp+ versus 3xdpp+ progeny ratio 0.01 (8/896). This is significant because 1xdpp+ survivors were never found in the progeny of wild-type females (n > 5000) or eIF4A1006/+ females (n > 2000). However, in the progeny of lackKG07014/+;hs–Gal4/UAS–TkvQD females, the ratio was not significantly different from that of lackKG07014/+ females (Fig. 4a). Taken together with previous results16,11, the synergy between eIF4A and DSmurf strongly indicates that they function in the same biological process — that is, promoting Mad protein degradation.

Second, we tested whether the effects of eIF4A mutations on Dpp signalling depend on DSmurf. Flies without DSmurf (lackKG07014/Df) were viable and fertile, and the females produced progeny in which the ratio of 1xdpp+ versus 3xdpp+ animals was >1.5 (Fig. 4a). However, animals with a half dose of eIF4A+ in this genetic background (eIF4A1006/+;lackKG07014/Df), although perfectly viable, resulted in complete lethality of 3xdpp+ offspring (ratio = 8; Fig. 4a). Flies heterozygous for eIF4AR321H in the absence of DSmurf (eIF4AR321H/+;lackKG07014/Df) were barely viable (10.5% viable; n = 228) and completely sterile, whereas either eIF4AR321H/+ or lackKG07014/Df flies separately were perfectly viable and fertile (data not shown). Thus, eIF4A mutations further enhance the mutant phenotypes of flies without DSmurf.

To further substantiate this finding, we examined eIF4A embryos lacking both maternal and zygotic DSmurf. Increased Dpp signalling can lead to expansion of dorsal/lateral cell fates at the expense of ventral cell fates. We found that although embryos produced by either eIF4A1006/+ or lackKG07014/Df females (crossed to lackKG07014/Df males) exhibited no significant dorsalization, those from eIF4A1006/+;lackKG07014/Df females were moderately (yet significantly) dorsalized, and embryos from eIF4AR321H/+;lackKG07014/Df females were completely dorsalized (Fig. 4b). Consistent with these results, embryos from eIF4A1006/+;lackKG07014/Df females exhibit more pronounced Mad accumulation (Fig. 4c). Thus, reducing eIF4A can further increase Dpp signalling and Mad accumulation in the absence of DSmurf. These results indicate that eIF4A and DSmurf can function independently in controlling Mad degradation.

In conclusion, our results indicate that eIF4A plays an essential role in limiting the duration and spatial distribution of Dpp signalling by promoting Mad/Medea degradation. We propose that in the absence of Dpp signals, eIF4A is able to physically associate with both Mad and Medea. Following the activation of the Dpp pathway, eIF4A promotes the ubiquitination and degradation of Mad and Medea, leading to attenuation and termination of Dpp signalling. eIF4A may function as an adaptor that links SMAD proteins to a degradation system that can be independent of the ubiquitin ligase DSmurf. We found no evidence that eIF4A mutations affect the Hedgehog and Wingless signalling pathways by genetic interaction analyses (see Supplementary Information, Fig. S4), thus eIF4A seems to be a specific regulator of Dpp signalling.


Fly stocks and genetics

All crosses were carried out at 25 °C on standard cornmeal/agar medium. eIF4AR321H and transgenic flies carrying UAS–eIF4A and UAS–eIF4AR321H were as described previously1. UAS–TkvQD, UAS–PutDN and UAS–SaxDN were as described previously13,18. The P-element-associated eIF4A alleles (eIF4A1069 and eIF4A1006) were as described previously3. Sp dppH 46/CyO-23 flies have the 0xdpp+/2xdpp+ genotype, as they carry a dpp null mutation (0xdpp+) and two doses of dpp+ on the CyO-23 balancer chromosome: the endogenous dpp+ and a p[dpp+] transgene, as previously described1,5. Crossing females (dpp+/dpp+) to Sp dppH 46/CyO-23 males produces 1xdpp+ and 3xdpp+ animals in the F1 progeny, allowing determination of their ratios. The Mad sax double-mutant stock Df(2L)JS17 sax1/CyO-23 is as described previously5. Df(2L)JS17 is a deficiency that removes Mad, thus was used as a null allele of Mad. Somatic mutant clones for tkv4 and eIF4A1069 were generated using the FLP–FRT method by crossing FRT40A tkv4/CyO or FRT40A eIF4A1069/CyO flies to hs–flp;FRT40A or hs–Myc [Au: OK?], respectively. The resulting larvae were heat-shocked for 2 h at 37 °C during the 2nd and early 3rd instar larval stages and dissected at the late 3rd instar stage. A brief heat-shock was administered 15 min before dissection to increase hs–Myc expression for marking the clones. All other stocks, including DSmurf mutants (lackKG07014 and Df(2R)Exel7149), eIF4A–lacZ and dpp–lacZ enhancer traps (eIF4Ak01501, eIF4A02439 and dppP10638), and various tissue-specific Gal4 lines, including C96–Gal4 (ref. 19), hs–Gal4, GMR–Gal4 and UAS–dpp were from public Drosophila stock centres or as described previously1. lackKG07014 seemed to be a stronger allele than the reported null allele lack15C (ref. 11), based on the observation that, when mated to dppH 46/CyO-23 males, lackKG07014/+ mothers produced 25% viable 1xdpp+ progeny, whereas <3% 1xdpp+ animals survived from lack15C/+ mothers (also see ref. 11).

Plasmids and antibodies

His-tagged full-length and N- and C-terminal eIF4A constructs were made by ligating PCR-amplified eIF4A or eIF4AR321H cDNA fragments1 to pQE vectors (Stratagene, La Jolla, CA) and subsequently subcloned into pcDNA3 (Invitrogen, Carlsbsd, CA). PCR primers for eIF4A-N and eIF4A-C were cgatGAGCTCggatgaccgaaatgagata (forward) and cgcaTCTAGAtaa tgggggcagcatcttgaa (reverse), and ctatGAGCTCtttcaagatgctgccccca (forward) and cgcaTCTAGAgcggctcagcagaaaaaa (reverse), respectively. The R321H substitution was located in the C terminus. Flag–Mad, Myc–Medea and TKVQD constructs (generous gifts from M. Kawabata) were as described previously20.

The primary antibodies (dilutions) used for whole-mount immunostaining and western blots were: rabbit anti-eIF4A (a gift from P. Lasko, McGill University, Canada; 1:300), sheep anti-eIF4A-c (a gift from C. Proud, University of British Columbia, Canada; 1:300), rabbit anti-pMad (PS1; a gift from P. ten Dijke, The Netherlands Cancer Institute, The Netherlands; 1:100), mouse anti-Myc (9E10; Developmental Hybridoma Bank, Iowa City, IA; 1:50), anti-Flag (M2; Sigma, St Louis, MO; 1:1000), mouse anti-β-gal (Promega, Madison, WI; 1:1000), goat anti-Mad (Santa Cruz, Santa Cruz, CA; 1:250) and anti-polyhistidine (Sigma; 1:2000). Different fluorophore-conjugated secondary antibodies were obtained from Molecular Probes (Carlsbad, CA; 1:250). HRP-conjugated secondary antibodies (Promega; 1:1000) were used for western blots.

Cell culture and immunoprecipitation

293T cells were cultured in DMEM (Invitrogen) supplemented with 10% fetal bovine serum in six-well plates. Cells were transfected with appropriate expression plasmids using FuGene 6 (Roche, Basel, Switzerland) according to the manufacturer’s instructions. Cells were harvested 48 h after transfection and were stained with the indicated antibodies or lysed in cell lysis buffer (20 mM Tris-HCl at pH 7.5, 150 mM NaCl, 1 mM Na2EDTA, 1 mM EGTA, 1% Triton-X-100, 2.5 mM sodium pyrophosphate, 1 mM β-glycerophosphate, 1 mM Na3VO4, 1 μg ml−1 leupeptin) (Cell Signaling Technology, Danvers, MA) for immunoprecipitation or SDS–PAGE. For proteosome inhibition, MG-132 (Sigma) was added at 50 μM 4 h prior to lysis. To immunoprecipitate endogenous Mad or eIF4A, extracts from 200 Drosophila embryos (0–24 h old) of appropriate genotype were used.

Pull-down and in vitro translation assays

1 μg of bacterially expressed His-tagged eIF4A protein was incubated with 200 μl of embryo extracts (in cell lysis buffer; see above) and 20 μl of Ni-NTA agarose beads for 2 h at room temperature. The Ni-NTA agarose beads were spun down and washed in the same buffer and subjected to SDS–PAGE to analyze bound proteins by western blotting with anti-Mad and anti-eIF4A.

In vitro translation was performed using the TNT® T7 Coupled Reticulocyte Lysate System in conjunction with the Transcend™ Colorimetric Non-Radioactive Translation Detection System (Promega) as per the manufacturer’s instructions. His-tagged eIF4A proteins expressed in Escherichia coli and quantified by SDS–PAGE, followed by Coomassie Blue staining, were included in the assays. The translation rate was measured by the amount of firefly luciferase (internal positive control provided by the Kit) produced, which had incorporated biotinylated lysine and was detected by the Colorimetric (BCIP/NBT) reagents following SDS–PAGE and transfer per the manufacturer’s instructions.

Supplementary Material


We thank S. Matics for technical assistance, M. Kawabata, P. Lasko, P. ten Dijke, C. Proud, W. Gelbart, D. Bohmann, Y. Sun, J. Zhao, J. Jiang, C. Proschel, and the Bloomington Drosophila Stock Center for various reagents and Drosophila strains. We thank Y. Sun for insightful discussions regarding possible mechanisms of eIF4A involvement in Dpp signalling and comments on the manuscript. J.L. was a recipient of the Wilmot Cancer Research Fellowship from the James P. Wilmot Foundation. This study was supported, in part, by grants from the National Institutes of Health (R01GM65774; R01GM077046) and an American Cancer Society Research Scholar Grant (RSG-06-196-01-TBE) to W.X.L.



J.L. coplanned the project, performed experiments and analysed data. W.X.L. planned the project and wrote the paper.


The authors declare that they have no competing financial interests.

Reprints and permission information is available online at

Note: Supplementary Information is available on the Nature Cell Biology website.


1. Li J, Li WX, Gelbart WM. A genetic screen for maternal-effect suppressors of decapentaplegic identifies the eukaryotic translation initiation factor 4A in Drosophila. Genetics. 2006;171:1629–1641. [PubMed]
2. Wharton KA, Ray RP, Gelbart WM. An activity gradient of decapentaplegic is necessary for the specification of dorsal pattern elements in the Drosophila embryo. Development. 1993;117:807–822. [PubMed]
3. Galloni M, Edgar BA. Cell-autonomous and non-autonomous growth-defective mutants of Drosophila melanogaster. Development. 1999;126:2365–2375. [PubMed]
4. Newfeld SJ, et al. Mothers against dpp participates in a DDP/TGF-β responsive serine-threonine kinase signal transduction cascade. Development. 1997;124:3167–3176. [PubMed]
5. Sekelsky JJ, Newfeld SJ, Raftery LA, Chartoff EH, Gelbart WM. Genetic characterization and cloning of mothers against dpp, a gene required for decapentaplegic function in Drosophila melanogaster. Genetics. 1995;139:1347–1358. [PubMed]
6. Brummel TJ, et al. Characterization and relationship of Dpp receptors encoded by the saxophone and thick veins genes in Drosophila. Cell. 1994;78:251–261. [PubMed]
7. Penton A, et al. Identification of two bone morphogenetic protein type I receptors in Drosophila and evidence that Brk25D is a decapentaplegic receptor. Cell. 1994;78:239–250. [PubMed]
8. Xie T, Finelli AL, Padgett RW. The Drosophila saxophone gene: a serine-threonine kinase receptor of the TGF-β superfamily. Science. 1994;263:1756–1759. [PubMed]
9. Nellen D, Affolter M, Basler K. Receptor serine/threonine kinases implicated in the control of Drosophila body pattern by decapentaplegic. Cell. 1994;78:225–237. [PubMed]
10. Dorfman R, Shilo BZ. Biphasic activation of the BMP pathway patterns the Drosophila embryonic dorsal region. Development. 2001;128:965–972. [PubMed]
11. Podos SD, Hanson KK, Wang YC, Ferguson EL. The DSmurf ubiquitin-protein ligase restricts BMP signaling spatially and temporally during Drosophila embryogenesis. Dev Cell. 2001;1:567–578. [PubMed]
12. Brand AH, Perrimon N. Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development. 1993;118:401–415. [PubMed]
13. Nellen D, Burke R, Struhl G, Basler K. Direct and long-range action of a DPP morphogen gradient. Cell. 1996;85:357–368. [PubMed]
14. Hudson JB, Podos SD, Keith K, Simpson SL, Ferguson EL. The Drosophila Medea gene is required downstream of dpp and encodes a functional homolog of human Smad4. Development. 1998;125:1407–1420. [PubMed]
15. Wisotzkey RG, et al. Medea is a Drosophila Smad4 homolog that is differentially required to potentiate DPP responses. Development. 1998;125:1433–1445. [PubMed]
16. Liang YY, et al. dSmurf selectively degrades decapentaplegic-activated MAD, and its overexpression disrupts imaginal disc development. J Biol Chem. 2003;278:26307–26310. [PubMed]
17. Lachance PE, Miron M, Raught B, Sonenberg N, Lasko P. Phosphorylation of eukaryotic translation initiation factor 4E is critical for growth. Mol Cell Biol. 2002;22:1656–1663. [PMC free article] [PubMed]
18. Haerry TE, Khalsa O, O’Connor MB, Wharton KA. Synergistic signaling by two BMP ligands through the SAX and TKV receptors controls wing growth and patterning in Drosophila. Development. 1998;125:3977–3987. [PubMed]
19. Gustafson K, Boulianne GL. Distinct expression patterns detected within individual tissues by the GAL4 enhancer trap technique. Genome. 1996;39:174–182. [PubMed]
20. Inoue H, et al. Interplay of signal mediators of decapentaplegic (Dpp): molecular characterization of mothers against dpp, Medea, and daughters against dpp. Mol Biol Cell. 1998;9:2145–2156. [PMC free article] [PubMed]